Clear Cell Ependymoma

A Clinicopathologic and Radiographic Analysis of 10 Patients

Maryam Fouladi, Kathleen Helton, James Dalton, Elizabeth Gilger, Amar Gajjar, Thomas Merchant, Larry Kun, Irene Newsham, Peter Burger, Christine Fuller

Research output: Contribution to journalArticle

Abstract

BACKGROUND. Clear cell ependymoma (CCE) is an uncommon central nervous system tumor with a predilection for the supratentorial region in children. Histologically, it may mimic oligodendroglioma, central neurocytoma, hemangioblastoma, and renal cell carcinoma. METHODS. The authors reviewed the clinical, radiographic, and pathologic features, therapy, and outcome in 10 children with CCE who were treated at St. Jude Children's Research Hospital (1984-2003). Fluorescence in situ hybridization (FISH) was performed using 1p/1q, 19p/19q, CEP18/DAL1, and bcr/NF2 probe pairs. RESULTS. The median patient age at diagnosis was 7.5 years (range, 1-19 years). Tumors occurred supratentorially in 9 of 10 patients. All tumors had rounded nuclei with surrounding, clear halos and at least focal perivascular pseudorosettes. Seven tumors had anaplastic features. No deletions involving 1p, 19q, or NF2 were detected. The tumors from 5 of 7 patients, all with anaplasia, had losses of both CEP18 and DAL-1. Radiographically, all tumors were enhanced, and 9 tumors had associated cysts with enhancing walls. Seven patients underwent gross total resection, which was near total in one patient and subtotal in two patients. Five patients received immediate postoperative local radiotherapy. Three patients were diagnosed initially with pilocytic astrocytoma (one patient) and oligodendroglioma (two patients) and were observed. The progression-free survival and overall survival rates at 5 years were 34% ± 20% and 75% ± 19%, respectively. The median follow-up was 37 months (range, 5-239 months). Five patients developed local recurrence within a median of 9 months after diagnosis. Two patients developed extracranial soft tissue and lymph node metastases. CONCLUSIONS. CCEs were found to have a predilection for extraneural metastases and early recurrence and demonstrate characteristic radiographic features, anaplastic histologic features, and chromosome 18 losses. The authors recommend resection followed by local radiotherapy as the treatment of choice in children.

Original languageEnglish (US)
Pages (from-to)2232-2244
Number of pages13
JournalCancer
Volume98
Issue number10
DOIs
StatePublished - Nov 15 2003

Fingerprint

Ependymoma
Oligodendroglioma
Neoplasms
Radiotherapy
Neurocytoma
Anaplasia
Hemangioblastoma
Neoplasm Metastasis
Chromosomes, Human, Pair 18
Recurrence
Central Nervous System Neoplasms
Astrocytoma
Fluorescence In Situ Hybridization
Renal Cell Carcinoma
Disease-Free Survival
Cysts
Survival Rate

Keywords

  • Clear cell ependymoma
  • DAL-1
  • NF2
  • Pediatric
  • Radiation therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fouladi, M., Helton, K., Dalton, J., Gilger, E., Gajjar, A., Merchant, T., ... Fuller, C. (2003). Clear Cell Ependymoma: A Clinicopathologic and Radiographic Analysis of 10 Patients. Cancer, 98(10), 2232-2244. https://doi.org/10.1002/cncr.11783

Clear Cell Ependymoma : A Clinicopathologic and Radiographic Analysis of 10 Patients. / Fouladi, Maryam; Helton, Kathleen; Dalton, James; Gilger, Elizabeth; Gajjar, Amar; Merchant, Thomas; Kun, Larry; Newsham, Irene; Burger, Peter; Fuller, Christine.

In: Cancer, Vol. 98, No. 10, 15.11.2003, p. 2232-2244.

Research output: Contribution to journalArticle

Fouladi, M, Helton, K, Dalton, J, Gilger, E, Gajjar, A, Merchant, T, Kun, L, Newsham, I, Burger, P & Fuller, C 2003, 'Clear Cell Ependymoma: A Clinicopathologic and Radiographic Analysis of 10 Patients', Cancer, vol. 98, no. 10, pp. 2232-2244. https://doi.org/10.1002/cncr.11783
Fouladi M, Helton K, Dalton J, Gilger E, Gajjar A, Merchant T et al. Clear Cell Ependymoma: A Clinicopathologic and Radiographic Analysis of 10 Patients. Cancer. 2003 Nov 15;98(10):2232-2244. https://doi.org/10.1002/cncr.11783
Fouladi, Maryam ; Helton, Kathleen ; Dalton, James ; Gilger, Elizabeth ; Gajjar, Amar ; Merchant, Thomas ; Kun, Larry ; Newsham, Irene ; Burger, Peter ; Fuller, Christine. / Clear Cell Ependymoma : A Clinicopathologic and Radiographic Analysis of 10 Patients. In: Cancer. 2003 ; Vol. 98, No. 10. pp. 2232-2244.
@article{200eaf9b8be049e9ae72a2a46f377293,
title = "Clear Cell Ependymoma: A Clinicopathologic and Radiographic Analysis of 10 Patients",
abstract = "BACKGROUND. Clear cell ependymoma (CCE) is an uncommon central nervous system tumor with a predilection for the supratentorial region in children. Histologically, it may mimic oligodendroglioma, central neurocytoma, hemangioblastoma, and renal cell carcinoma. METHODS. The authors reviewed the clinical, radiographic, and pathologic features, therapy, and outcome in 10 children with CCE who were treated at St. Jude Children's Research Hospital (1984-2003). Fluorescence in situ hybridization (FISH) was performed using 1p/1q, 19p/19q, CEP18/DAL1, and bcr/NF2 probe pairs. RESULTS. The median patient age at diagnosis was 7.5 years (range, 1-19 years). Tumors occurred supratentorially in 9 of 10 patients. All tumors had rounded nuclei with surrounding, clear halos and at least focal perivascular pseudorosettes. Seven tumors had anaplastic features. No deletions involving 1p, 19q, or NF2 were detected. The tumors from 5 of 7 patients, all with anaplasia, had losses of both CEP18 and DAL-1. Radiographically, all tumors were enhanced, and 9 tumors had associated cysts with enhancing walls. Seven patients underwent gross total resection, which was near total in one patient and subtotal in two patients. Five patients received immediate postoperative local radiotherapy. Three patients were diagnosed initially with pilocytic astrocytoma (one patient) and oligodendroglioma (two patients) and were observed. The progression-free survival and overall survival rates at 5 years were 34{\%} ± 20{\%} and 75{\%} ± 19{\%}, respectively. The median follow-up was 37 months (range, 5-239 months). Five patients developed local recurrence within a median of 9 months after diagnosis. Two patients developed extracranial soft tissue and lymph node metastases. CONCLUSIONS. CCEs were found to have a predilection for extraneural metastases and early recurrence and demonstrate characteristic radiographic features, anaplastic histologic features, and chromosome 18 losses. The authors recommend resection followed by local radiotherapy as the treatment of choice in children.",
keywords = "Clear cell ependymoma, DAL-1, NF2, Pediatric, Radiation therapy",
author = "Maryam Fouladi and Kathleen Helton and James Dalton and Elizabeth Gilger and Amar Gajjar and Thomas Merchant and Larry Kun and Irene Newsham and Peter Burger and Christine Fuller",
year = "2003",
month = "11",
day = "15",
doi = "10.1002/cncr.11783",
language = "English (US)",
volume = "98",
pages = "2232--2244",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Clear Cell Ependymoma

T2 - A Clinicopathologic and Radiographic Analysis of 10 Patients

AU - Fouladi, Maryam

AU - Helton, Kathleen

AU - Dalton, James

AU - Gilger, Elizabeth

AU - Gajjar, Amar

AU - Merchant, Thomas

AU - Kun, Larry

AU - Newsham, Irene

AU - Burger, Peter

AU - Fuller, Christine

PY - 2003/11/15

Y1 - 2003/11/15

N2 - BACKGROUND. Clear cell ependymoma (CCE) is an uncommon central nervous system tumor with a predilection for the supratentorial region in children. Histologically, it may mimic oligodendroglioma, central neurocytoma, hemangioblastoma, and renal cell carcinoma. METHODS. The authors reviewed the clinical, radiographic, and pathologic features, therapy, and outcome in 10 children with CCE who were treated at St. Jude Children's Research Hospital (1984-2003). Fluorescence in situ hybridization (FISH) was performed using 1p/1q, 19p/19q, CEP18/DAL1, and bcr/NF2 probe pairs. RESULTS. The median patient age at diagnosis was 7.5 years (range, 1-19 years). Tumors occurred supratentorially in 9 of 10 patients. All tumors had rounded nuclei with surrounding, clear halos and at least focal perivascular pseudorosettes. Seven tumors had anaplastic features. No deletions involving 1p, 19q, or NF2 were detected. The tumors from 5 of 7 patients, all with anaplasia, had losses of both CEP18 and DAL-1. Radiographically, all tumors were enhanced, and 9 tumors had associated cysts with enhancing walls. Seven patients underwent gross total resection, which was near total in one patient and subtotal in two patients. Five patients received immediate postoperative local radiotherapy. Three patients were diagnosed initially with pilocytic astrocytoma (one patient) and oligodendroglioma (two patients) and were observed. The progression-free survival and overall survival rates at 5 years were 34% ± 20% and 75% ± 19%, respectively. The median follow-up was 37 months (range, 5-239 months). Five patients developed local recurrence within a median of 9 months after diagnosis. Two patients developed extracranial soft tissue and lymph node metastases. CONCLUSIONS. CCEs were found to have a predilection for extraneural metastases and early recurrence and demonstrate characteristic radiographic features, anaplastic histologic features, and chromosome 18 losses. The authors recommend resection followed by local radiotherapy as the treatment of choice in children.

AB - BACKGROUND. Clear cell ependymoma (CCE) is an uncommon central nervous system tumor with a predilection for the supratentorial region in children. Histologically, it may mimic oligodendroglioma, central neurocytoma, hemangioblastoma, and renal cell carcinoma. METHODS. The authors reviewed the clinical, radiographic, and pathologic features, therapy, and outcome in 10 children with CCE who were treated at St. Jude Children's Research Hospital (1984-2003). Fluorescence in situ hybridization (FISH) was performed using 1p/1q, 19p/19q, CEP18/DAL1, and bcr/NF2 probe pairs. RESULTS. The median patient age at diagnosis was 7.5 years (range, 1-19 years). Tumors occurred supratentorially in 9 of 10 patients. All tumors had rounded nuclei with surrounding, clear halos and at least focal perivascular pseudorosettes. Seven tumors had anaplastic features. No deletions involving 1p, 19q, or NF2 were detected. The tumors from 5 of 7 patients, all with anaplasia, had losses of both CEP18 and DAL-1. Radiographically, all tumors were enhanced, and 9 tumors had associated cysts with enhancing walls. Seven patients underwent gross total resection, which was near total in one patient and subtotal in two patients. Five patients received immediate postoperative local radiotherapy. Three patients were diagnosed initially with pilocytic astrocytoma (one patient) and oligodendroglioma (two patients) and were observed. The progression-free survival and overall survival rates at 5 years were 34% ± 20% and 75% ± 19%, respectively. The median follow-up was 37 months (range, 5-239 months). Five patients developed local recurrence within a median of 9 months after diagnosis. Two patients developed extracranial soft tissue and lymph node metastases. CONCLUSIONS. CCEs were found to have a predilection for extraneural metastases and early recurrence and demonstrate characteristic radiographic features, anaplastic histologic features, and chromosome 18 losses. The authors recommend resection followed by local radiotherapy as the treatment of choice in children.

KW - Clear cell ependymoma

KW - DAL-1

KW - NF2

KW - Pediatric

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=0242611586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242611586&partnerID=8YFLogxK

U2 - 10.1002/cncr.11783

DO - 10.1002/cncr.11783

M3 - Article

VL - 98

SP - 2232

EP - 2244

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 10

ER -